What does it mean when a company clears its single biggest regulatory hurdle of the decade and the stock falls anyway?
That is the situation Coforge is sitting in right now. The Reserve Bank of India has approved the company’s overseas investment exceeding $1 billion for the Encora acquisition. That is the green light for the most consequential strategic move Coforge has made in its existence. And the market, as of March 31, 2026, is pricing the stock at ₹1,115 on NSE. The 52-week high was ₹1,994. That is a 44% drawdown. The 52-week low is ₹1,008. So the current price is not in the middle of a range — it is parked at the bottom, about a hundred rupees above the floor.
The macro story is real and I am not dismissing it. The Nifty 50 has pulled back from its 52-week high, reflecting genuine pressure from ground operations in West Asia, global bond yields unsettling risk assets, and a rupee that has softened against the dollar. These are live variables.
But here is what I think is happening: the market has lumped Coforge into a category — “high-beta Indian IT, sell on risk-off” — and stopped doing the underlying work. The category trade is dominating the company-specific read.
The Encora Deal Is Not a Capacity Addition
Encora is a digital engineering and product development firm. It is not a body-shop acquisition or a revenue-scale play in the traditional IT services sense. When Coforge moves to absorb Encora at this price and at this moment, it is making a directional bet: that enterprise demand for high-end digital engineering services will recover, and that companies positioned at the premium end of that stack will capture disproportionate margin when it does.
Peers like Mphasis and LTIMindtree have been running cautious guidance. The sector-level narrative is defensive. Coforge’s response to that environment was to go get RBI approval and push a billion dollars into an expansion. That is either reckless or it is a read on the cycle that the current stock price does not reflect. I lean toward the latter, though the weakest assumption in this entire case is that integration will proceed on a timeline fast enough to matter before debt costs compound.
The rupee dynamic is worth unpacking separately. In a standard IT services cycle, a weaker rupee is a margin tailwind — revenues are dollar-denominated, costs are rupee-denominated, so depreciation fattens the spread. That logic has not disappeared. What has happened is that the current narrative has inverted the frame: investors are reading rupee weakness through the lens of debt servicing on a dollar-denominated acquisition. A billion-dollar deal financed with debt, in a high-rate environment, with a currency moving against you on the liability side — that is a real cost structure issue.
The question is whether that concern is already in the price. At ₹1,115, sitting 10% above its 52-week low and 44% off the high, I think a substantial amount of that worry is already discounted. The stock is not being priced as a company that just secured regulatory approval for a transformational acquisition. It is being priced as a company in managed decline. At least one of those readings is wrong.
The Variable the Market Is Not Tracking
The silent variable is integration speed versus debt cost. If Coforge can pull Encora’s digital-first portfolio into its delivery structure quickly — extracting margin synergies before the interest expense compounds into a visible drag on earnings — then the bear case loses its primary mechanism. If integration runs slow and debt servicing runs hot, the stock deserves to be where it is.
I do not have a precise timeline for that integration. Nobody outside the company does. What I do know is that the RBI approval removes the most binary risk in the near-term setup. The deal was not guaranteed to clear. It has cleared. That is a resolved uncertainty, and resolved uncertainties in the direction of “yes, proceed” are typically worth something. In this case, the stock moved lower anyway, which tells you how much weight the macro is carrying versus fundamentals.
The chart makes the point plainly. From ₹1,712 on February 1 per NSE closing data to ₹1,115 by March 31 — a nearly uninterrupted decline through the period when the RBI approval was being finalized and ultimately granted. The approval did not arrest the selling. That is not evidence the deal is bad. It is evidence that the selling is not about the deal.
Which is exactly the contrarian setup. When a stock falls for reasons unrelated to its fundamental trajectory, the price and the business diverge. The question is always how long that divergence persists and whether the catalyst to close it is identifiable. Here, the catalyst would be Encora integration milestones showing up in earnings — early margin data, revenue contribution visibility, reduction in debt overhang. Those are not guaranteed, but they are dateable. They will either appear in the next two to three reporting cycles or they will not.
The dominant narrative right now is that Coforge is a macro casualty — a high-beta name caught in a sector rotation and a risk-off environment. That narrative is not wrong about what happened to the price. It may be entirely wrong about what the price means going forward. A company that just received regulatory clearance to double its strategic scale is not the same as one whose growth story has ended. The market is treating them identically. The sector’s cyclical downturn is already priced in; Coforge’s structural transformation is not. That gap — between what the company just did and what the stock price implies about it — is where the contrarian case lives.
Whether the gap closes in six months or two years, or whether integration stumbles and closes it in the wrong direction, is genuinely unknown. But the price at ₹1,115 is close enough to the 52-week floor that the asymmetry is worth sitting with.
The market spent six months marking Coforge down for things that haven’t happened yet, then ignored the one thing that actually did.